Cited by 1,048Infectious Encephalopathies and EncephalitisLong-Term Effects of COVID-19Respiratory viral infections research

The DOI matches its Crossref record; 342 of the 342 references it cites were found in a registry or an index.

Human Coronaviruses and Other Respiratory Viruses: Underestimated Opportunistic Pathogens of the Central Nervous System?

Open access

Desforges, Marc, Le Coupanec, Alain, Dubeau, Philippe, Bourgouin, Andréanne, Lajoie, Louise, Dubé, Mathieu, Talbot, Pierre J.·2019·Viruses

DOI 10.3390/v12010014PMC PMC7020001

Open this paper in CoChat — free account Open PDF

Abstract

Respiratory viruses infect the human upper respiratory tract, mostly causing mild diseases. However, in vulnerable populations, such as newborns, infants, the elderly and immune-compromised individuals, these opportunistic pathogens can also affect the lower respiratory tract, causing a more severe disease (e.g., pneumonia). Respiratory viruses can also exacerbate asthma and lead to various types of respiratory distress syndromes. Furthermore, as they can adapt fast and cross the species barrier, some of these pathogens, like influenza A and SARS-CoV, have occasionally caused epidemics or pandemics, and were associated with more serious clinical diseases and even mortality. For a few decades now, data reported in the scientific literature has also demonstrated that several respiratory viruses have neuroinvasive capacities, since they can spread from the respiratory tract to the central nervous system (CNS). Viruses infecting human CNS cells could then cause different types of encephalopathy, including encephalitis, and long-term neurological diseases. Like other well-recognized neuroinvasive human viruses, respiratory viruses may damage the CNS as a result of misdirected host immune responses that could be associated with autoimmunity in susceptible individuals (virus-induced neuro-immunopathology) and/or viral replication, which directly causes damage to CNS cells (virus-induced neuropathology). The etiological agent of several neurological disorders remains unidentified. Opportunistic human respiratory pathogens could be associated with the triggering or the exacerbation of these disorders whose etiology remains poorly understood. Herein, we present a global portrait of some of the most prevalent or emerging human respiratory viruses that have been associated with possible pathogenic processes in CNS infection, with a special emphasis on human coronaviruses.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.3390/v12010014

Cites

342 of 342 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The environment and disease: association or causation?
Hill, A. B. (2015) · Journal of the Royal Society of Medicine · doi:10.1177/0141076814562718 · Cited by 7,804
The Environment and Disease: Association or Causation?
Hill, A. B. (1965) · Proceedings of the Royal Society of Medicine · doi:10.1177/003591576505800503 · Cited by 6,974
Isolation of a Novel Coronavirus from a Man with Pneumonia in Saudi Arabia
Zaki, A. M., van Boheemen, S., Bestebroer, T. M., Osterhaus, A. D. M. E., & Fouchier, R. A. M. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1211721 · Cited by 5,677
Identification of a novel coronavirus in patients with severe acute respiratory syndrome
Drosten, C., Günther, S., Preiser, W., van der Werf, S., Brodt, H.-R., Becker, S., Rabenau, H., Panning, M., Kolesnikova, L., Fouchier, R. A. M., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030747 · Cited by 4,574
A Novel Coronavirus Associated with Severe Acute Respiratory Syndrome
Tg, K., Erdman, D. D., Cs, G., Zaki, Peret, T. C. T., Emery, S. L., Tong, S., Urbani, C., Comer, J. A., Lim, W., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030781 · Cited by 4,353
Coronaviruses: An Overview of Their Replication and Pathogenesis
Fehr, A. R., & Perlman, S. M. (2015) · Methods in molecular biology · doi:10.1007/978-1-4939-2438-7_1 · Cited by 3,910
Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis
Nair, H., Nokes, D. J., Gessner, B. D., Dherani, M., Madhi, S. A., Singleton, R. J., O'Brien, K. L., Roca, A., Wright, P. F., Bruce, N., et al. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60206-1 · Cited by 2,773
Bats Are Natural Reservoirs of SARS-Like Coronaviruses
Li, W., Shi, Z., Yu, M., Ren, W., Smith, C. S., Epstein, J. H., Wang, H., Crameri, G. S., Hú, Z., Zhang, H., et al. (2005) · Science · doi:10.1126/science.1118391 · Cited by 2,571
Molecular definitions of cell death subroutines: recommendations of the Nomenclature Committee on Cell Death 2012
Galluzzi, L., Vitale, I., Abrams, J. M., Alnemri, E. S., Baehrecke, E. H., Blagosklonny, M. V., Dawson, T. M., Dawson, V. L., El-Deiry, W. S., Fulda, S., et al. (2012) · Cell Death & Differentiation · doi:10.1038/cdd.2011.96 · Cited by 2,421
Isolation and Characterization of Viruses Related to the SARS Coronavirus from Animals in Southern China
Guan, Y., Zheng, B., He, Y., Liu, X. L., Zhuang, Z. X., Cheung, C. L., Luo, S., Li, P. H., Zhang, L., Guan, Y., et al. (2003) · Science · doi:10.1126/science.1087139 · Cited by 2,404

Flagged first, then by citations

Show all 341 references

Sorted by citations

Items 201–300 of 999

First case of focal epilepsy associated with SARS‐coronavirus‐2
Elgamasy, S., Kamel, M. G., Ghozy, S. A., Khalil, A. M., Morra, M. E., & Islam, S. M. S. (2020) · Journal of Medical Virology · doi:10.1002/jmv.26113 · Cited by 50
An updated min-review on environmental route of the SARS-CoV-2 transmission
Hoseinzadeh, E., Javan, S., Farzadkia, M., Mohammadi, F., Hossini, H., & Taghavi, M. (2020) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2020.111015 · Cited by 50
Stroke in Coronavirus Disease 2019: A Systematic Review
Bhatia, R., Pedapati, R., Komakula, S., Srivastava, M. V. P., Vishnubhatla, S., & Khuranac, D. (2020) · Journal of Stroke · doi:10.5853/jos.2020.02264 · Cited by 52
Neurological Symptoms of COVID-19: The Zonulin Hypothesis
Llorens, S., Nava, E., Muñoz, M., Sánchez‐Larsen, Á., & Segura, T. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.665300 · Cited by 50
Brain injury, endothelial injury and inflammatory markers are elevated and express sex-specific alterations after COVID-19
Savarraj, J. P. J., Park, E. S., Colpo, G. D., Hinds, S. N., Morales‐Scheihing, D., Ahnstedt, H. W., Paz, A. S., Assing, A., Liu, F., Juneja, S., et al. (2021) · Journal of Neuroinflammation · doi:10.1186/s12974-021-02323-8 · Cited by 52
COVID-19 Guide for the Rehabilitation Clinician
Lopez, M., Bell, K. R., Annaswamy, T. M., Juengst, S. B., & Ifejika, N. L. (2020) · American Journal of Physical Medicine & Rehabilitation · doi:10.1097/phm.0000000000001479 · Cited by 51
Quantification of Neurological Blood-Based Biomarkers in Critically Ill Patients With Coronavirus Disease 2019
Cooper, J. G., Stukas, S. K., Hoiland, R. L., Fergusson, N. A., Thiara, S., Foster, D., Mitra, A. R., Stoessl, A. J., Panenka, W. J., Sekhon, M. S., et al. (2020) · Critical Care Explorations · doi:10.1097/cce.0000000000000238 · Cited by 48
Pathophysiological Clues to How the Emergent SARS-CoV-2 Can Potentially Increase the Susceptibility to Neurodegeneration
Dolatshahi, M., Sabahi, M., & Aarabi, M. H. (2021) · Molecular Neurobiology · doi:10.1007/s12035-020-02236-2 · Cited by 51
Mental disorders, psychopharmacological treatments, and mortality in 2150 COVID‐19 Spanish inpatients
Díez, C., Iglesias-González, M., Giralt‐López, M., Rangil, T., Sanagustín, D., Moreira, M., López‐Ramentol, M., Ibáñez‐Caparrós, A., Lorán, M., Bustos‐Cardona, T., et al. (2021) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.13304 · Cited by 49
Post-Acute COVID-19 Neurological Syndrome: A New Medical Challenge
Nuzzo, D., Vasto, S., Scalisi, L., Cottone, S., Cambula, G., Rizzo, M., Giacomazza, D., & Picone, P. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10091947 · Cited by 50
Kidney injury in COVID-19 patients, drug development and their renal complications: Review study
Yarijani, Z. M., & Najafi, H. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.111966 · Cited by 52
COVID‐19: A systematic review and update on prevention, diagnosis, and treatment
Aliabadi, H. A. M., Eivazzadeh‐Keihan, R., Parikhani, A. B., Mehraban, S. F., Maleki, A. R., Fereshteh, S., Bazaz, M., Zolriasatein, A., Bozorgnia, B., Rahmati, S., et al. (2022) · MedComm · doi:10.1002/mco2.115 · Cited by 50
The cognitive and psychiatric subacute impairment in severe Covid-19
Serrano-Castro, P. J., Garzón-Maldonado, F. J., Naranjo, I. C., Ollero-Ortiz, A., Mínguez‐Castellanos, A., Iglesias-Espinosa, M., Baena-Palomino, P., Sánchez, V. S., Pérez, R. M. S., Rubi-Callejon, J., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-07559-9 · Cited by 52
COVID‐19: what if the brain had a role in causing the deaths?
Tassorelli, C., Mojoli, F., Baldanti, F., Bruno, R., & Benazzo, M. (2020) · European Journal of Neurology · doi:10.1111/ene.14275 · Cited by 49
Prolonged confusional state as first manifestation of COVID‐19
Butt, I., Sawlani, V., & Geberhiwot, T. (2020) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.51067 · Cited by 48
Ultrastructural Evidence of Direct Viral Damage to the Olfactory Complex in Patients Testing Positive for SARS-CoV-2
Morbini, P., Benazzo, M., Verga, L., Pagella, F., Mojoli, F., Bruno, R., & Marena, C. (2020) · JAMA Otolaryngology–Head & Neck Surgery · doi:10.1001/jamaoto.2020.2366 · Cited by 48
MiRNA-SARS-CoV-2 dialogue and prospective anti-COVID-19 therapies
Panda, M., Kalita, E., Singh, S., Kumar, K., Rao, A., & Prajapati, V. K. (2022) · Life Sciences · doi:10.1016/j.lfs.2022.120761 · Cited by 49
Matrix metalloproteinases are involved in the development of neurological complications in patients with Coronavirus disease 2019
Mohammadhosayni, M., Mohammadi, F. S., Ezzatifar, F., Gorabi, A. M., Khosrojerdi, A., Aslani, S., Hemmatzadeh, M., Yazdani, S., Arabi, M., Marofi, F., et al. (2021) · International Immunopharmacology · doi:10.1016/j.intimp.2021.108076 · Cited by 50
Neurobiology of coronaviruses: Potential relevance for COVID-19
Cataldi, M., Pignataro, G., & Taglialatela, M. (2020) · Neurobiology of Disease · doi:10.1016/j.nbd.2020.105007 · Cited by 51
Recent updates in COVID-19 with emphasis on inhalation therapeutics: Nanostructured and targeting systems
El‐Latif, A. A. A., Tawfeek, H. M., Abdelfattah, A. M., Batiha, G. E., & Hetta, ‏. F. (2021) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2021.102435 · Cited by 49
Assessment of Functional Mobility After COVID-19 in Adults Aged 50 Years or Older in the Canadian Longitudinal Study on Aging
Beauchamp, M. K., Joshi, D., McMillan, J. M., Oz, U. E., Griffith, L. E., Basta, N. E., Kirkland, S., Wolfson, C. M., Raina, P. S., Canadian Longitudinal Study on Aging (CLSA) Team, et al. (2022) · JAMA Network Open · doi:10.1001/jamanetworkopen.2021.46168 · Cited by 46
The brain, another potential target organ, needs early protection from SARS-CoV-2 neuroinvasion
Li, Z., Huang, Y., & Guo, X. (2020) · Science China Life Sciences · doi:10.1007/s11427-020-1690-y · Cited by 46
The Neat Dance of COVID-19: NEAT1, DANCR, and Co-Modulated Cholinergic RNAs Link to Inflammation
Meydan, C., Madrer, N., & Soreq, H. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.590870 · Cited by 48
Insulin fast-dissolving film for intranasal delivery via olfactory region, a promising approach for the treatment of anosmia in COVID-19 patients: Design, in-vitro characterization and clinical evaluation
Mohamad, S. A., Badawi, A. M., & Mansour, H. F. (2021) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2021.120600 · Cited by 47
Looking ahead
Pérez, C. A. (2020) · Neurology Clinical Practice · doi:10.1212/cpj.0000000000000836 · Cited by 45
A COVID-19 patient with intense burning pain
Aksan, F., Nelson, E. A., & Swedish, K. A. (2020) · Journal of NeuroVirology · doi:10.1007/s13365-020-00887-4 · Cited by 45
COVID-19 and Multiple Sclerosis: Predisposition and Precautions in Treatment
Sadeghmousavi, S., & Rezaei, N. (2020) · SN Comprehensive Clinical Medicine · doi:10.1007/s42399-020-00504-9 · Cited by 45
A Systematic Review of Severe Neurological Manifestations in Pediatric Patients with Coexisting SARS-CoV-2 Infection
O’Loughlin, L., Toledo, N. A., Budrie, L., Waechter, R. L., & Rayner, J. C. (2021) · Neurology International · doi:10.3390/neurolint13030041 · Cited by 45
Acute Necrotizing Encephalopathy Associated With SARS-CoV-2 Exposure in a Pediatric Patient
Lazarte-Rantes, C., Guevara, J. K., Romero, L., & Guillén–Pinto, D. (2021) · Cureus · doi:10.7759/cureus.15018 · Cited by 45
SARS-CoV-2 Brain Regional Detection, Histopathology, Gene Expression, and Immunomodulatory Changes in Decedents with COVID-19
Serrano, G. E., Walker, J. E., Tremblay, C., Piras, I. S., Huentelman, M. J., Belden, C. M., Goldfarb, D., Shprecher, D., Atri, A., Adler, C. H., et al. (2022) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nlac056 · Cited by 45
Self-citation
What can psychiatrists learn from SARS and MERS outbreaks?
Sommer, I. E., & Bakker, P. R. (2020) · The Lancet Psychiatry · doi:10.1016/s2215-0366(20)30219-4 · Cited by 44
New-onset refractory status epilepticus (NORSE) in post SARS-CoV-2 autoimmune encephalitis: a case report
Dono, F., Carrarini, C., Russo, M., Angelis, M. V. D., Anzellotti, F., ONOFRJ, M. C., & Bonanni, L. (2020) · Neurological Sciences · doi:10.1007/s10072-020-04846-z · Cited by 43
Neurological complications of COVID‐19 in hospitalized patients: The registry of a neurology department in the first wave of the pandemic
Sanchez, S., Sánchez‐Soblechero, A., Otalora, P. J. M., López, Á. R., Velilla-Alonso, G., Palacios-Mendoza, M., Caramé, C. C., Amaya‐Pascasio, L., Serrano, M. M., Massot‐Tarrús, A., et al. (2021) · European Journal of Neurology · doi:10.1111/ene.14748 · Cited by 42
The need for neurologists in the care of COVID‐19 patients
Sellner, J., Taba, P., Öztürk, Ş., & Helbok, R. (2020) · European Journal of Neurology · doi:10.1111/ene.14257 · Cited by 44
Neuroinvasion of SARS‐CoV‐2 may play a role in the breakdown of the respiratory center of the brain
Dey, J., Alam, M. T., Chandra, S., Gupta, J., Ray, U., Srivastava, A. K., & Tripathi, P. P. (2021) · Journal of Medical Virology · doi:10.1002/jmv.26521 · Cited by 43
A Review of Neuro-Ophthalmological Manifestations of Human Coronavirus Infection
Luís, M. E., Hipólito‐Fernandes, D., Mota, C., Maleita, D., Xavier, C., Maio, T., Cunha, J. P., & Ferreira, J. (2020) · Eye and Brain · doi:10.2147/eb.s268828 · Cited by 43
Post-COVID Pain Syndromes
Fiala, K. J., Martens, J. M., & Abd-Elsayed, A. A. (2022) · Current Pain and Headache Reports · doi:10.1007/s11916-022-01038-6 · Cited by 43
Human Coronavirus OC43 as a Low-Risk Model to Study COVID-19
Kim, M. I., & Lee, C.-H. (2023) · Viruses · doi:10.3390/v15020578 · Cited by 47
Pain as clinical manifestations of COVID-19 infection and its management in the pandemic era: a literature review
Widyadharma, I. P. E., Sari, N. N. S. P., Pradnyaswari, K. E., Yuwana, K. T., Adikarya, I. P. G. D., Tertia, C., Wijayanti, I. A. S., Indrayani, I. A. S., & Utami, D. K. I. (2020) · The Egyptian Journal of Neurology Psychiatry and Neurosurgery · doi:10.1186/s41983-020-00258-0 · Cited by 43
Central nervous system manifestations in COVID‐19 patients: A systematic review and meta‐analysis
Nazari, S., Jafari, A. A., Mirmoeeni, S., Sadeghian, S., Heidari, M. E., Sadeghian, S., Assarzadegan, F., Puormand, S. M., Alikhani, K., Ebadi, H., et al. (2021) · Brain and Behavior · doi:10.1002/brb3.2025 · Cited by 43
Investigation of pituitary functions after acute coronavirus disease 2019
Urhan, E., Karaca, Z., Ünüvar, G. K., Gündoğan, K., & Ünlühızarcı, K. (2022) · Endocrine Journal · doi:10.1507/endocrj.ej21-0531 · Cited by 45
Dementia Care in the Time of COVID-19 Pandemic
Tousi, B. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-200461 · Cited by 43
Abrupt Late-onset Psychosis as a Presentation of Coronavirus 2019 Disease (COVID-19): A Longitudinal Case Report
Parker, C., Slan, A. R., Shalev, D., & CRITCHFIELD, A. (2021) · Journal of Psychiatric Practice · doi:10.1097/pra.0000000000000533 · Cited by 40
The relationship between chronic immune response and neurodegenerative damage in long COVID-19
Elizalde-Díaz, J. P., Miranda-Narváez, C. L., Martínez‐Lazcano, J. C., & Martínez‐Martínez, E. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1039427 · Cited by 43
Seizure and COVID-19: Association and review of potential mechanism
Narula, N., Joseph, R., Katyal, N., Daouk, A., Acharya, S., Avula, A., & Maroun, R. (2020) · Neurology Psychiatry and Brain Research · doi:10.1016/j.npbr.2020.10.001 · Cited by 42
Covid19, beyond just the lungs: A review of multisystemic involvement by Covid19
Singh, A., Zaheer, S., Kumar, N., Singla, T., & Ranga, S. (2021) · Pathology - Research and Practice · doi:10.1016/j.prp.2021.153384 · Cited by 40
Neuropsychology of COVID-19: Anticipated cognitive and mental health outcomes.
Bailey, E. K., Steward, K. A., Jantz, A. B. V., Kamper, J. E., Mahoney, E. J., & Duchnick, J. J. (2021) · Neuropsychology · doi:10.1037/neu0000731 · Cited by 43
Psychosis during the COVID-19 pandemic: A systematic review of case reports and case series
Chaudhary, A. M. D., Musavi, N. B., Saboor, S., Javed, S., Khan, S., & Naveed, S. (2022) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2022.06.041 · Cited by 40
The Potential Role of SARS-COV-2 in the Pathogenesis of Parkinson's Disease
Chaná‐Cuevas, P., Salles, P. A., Rojas‐Fernández, A., Salinas-Rebolledo, C., & Milán, A. (2020) · Frontiers in Neurology · doi:10.3389/fneur.2020.01044 · Cited by 40
Modelling the Anatomic Distribution of Neurologic Events in Patients with COVID-19: A Systematic Review of MRI Findings
Parsons, N., Outsikas, A., Parish, A., Clohesy, R., Thakkar, N., D’Aprano, F., Toomey, F., Advani, S., & Poudel, G. R. (2021) · American Journal of Neuroradiology · doi:10.3174/ajnr.a7113 · Cited by 40
Neurological manifestations of COVID-19: a review of what we know so far
Gklinos, P. (2020) · Journal of Neurology · doi:10.1007/s00415-020-09939-5 · Cited by 40
Viral Infections and Schizophrenia: A Comprehensive Review
Kotsiri, I., Resta, P., Spyrantis, A., Panotopoulos, C., Chaniotis, D. I., Beloukas, A. I., & Magiorkinis, E. (2023) · Viruses · doi:10.3390/v15061345 · Cited by 40
Neurological Impact of Coronavirus Disease of 2019: Practical Considerations for the Neuroscience Community
Werner, C., Scullen, T. A., Mathkour, M., Zeoli, T. C., Beighley, A., Kilgore, M. D., Carr, C., Zweifler, R. M., Aysenne, A. M., Maulucci, C. M., et al. (2020) · World Neurosurgery · doi:10.1016/j.wneu.2020.04.222 · Cited by 40
Microglia Fighting for Neurological and Mental Health: On the Central Nervous System Frontline of COVID-19 Pandemic
de Andrade, E. G., Šimončičová, E., Carrier, M., Vecchiarelli, H. A., Robert, M.-È., & Tremblay, M. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2021.647378 · Cited by 39
Studying the neuropsychological sequelae of SARS-CoV-2: lessons learned from 35 years of neuroHIV research
Levine, A. J., Sacktor, N. C., & Becker, J. T. (2020) · Journal of NeuroVirology · doi:10.1007/s13365-020-00897-2 · Cited by 39
Gut Microbiota Dynamics in Relation to Long-COVID-19 Syndrome: Role of Probiotics to Combat Psychiatric Complications
Alenazy, M. F., Aljohar, H. I., Alruwaili, A. R., Daghestani, M. H., Alonazi, M. A., Labban, R. S. M., El‐Ansary, A. K., & Balto, H. A. G. (2022) · Metabolites · doi:10.3390/metabo12100912 · Cited by 39
COVID-19 and Parkinson’s Disease: Are We Dealing with Short-term Impacts or Something Worse?
Victorino, D. B., Guimarães‐Marques, M., Nejm, M. B., Scorza, F. A., & Scorza, C. A. (2020) · Journal of Parkinson s Disease · doi:10.3233/jpd-202073 · Cited by 37
Environmental Nanoparticles, SARS-CoV-2 Brain Involvement, and Potential Acceleration of Alzheimer’s and Parkinson’s Diseases in Young Urbanites Exposed to Air Pollution
Calderón‐Garcidueñas, L., Torres‐Jardón, R., Franco-Lira, M., Kulesza, R. J., González-Maciel, A., Reynoso-Robles, R., Brito-Aguilar, R., García-Arreola, B., Revueltas-Ficachi, P., Barrera-Velázquez, J. A., et al. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-200891 · Cited by 40
The Neurological Complexities and Prognosis of COVID-19
Padda, I., Khehra, N., Jaferi, U., & Parmar, M. S. (2020) · SN Comprehensive Clinical Medicine · doi:10.1007/s42399-020-00527-2 · Cited by 39
Clinical features of SARS-CoV-2-associated encephalitis and meningitis amid COVID-19 pandemic
Huo, L., Xu, K., & Wang, H. (2021) · World Journal of Clinical Cases · doi:10.12998/wjcc.v9.i5.1058 · Cited by 38
Observational cohort study of neurological involvement among patients with SARS-CoV-2 infection
Fleischer, M., Köhrmann, M., Dolff, S., Szepanowski, F., Schmidt, K., Herbstreit, F., Güngör, C., Stolte, B., Steiner, K. M., Stadtler, C., et al. (2021) · Therapeutic Advances in Neurological Disorders · doi:10.1177/1756286421993701 · Cited by 39
Impact of SARS-CoV-2 on neuropsychiatric disorders
Robinson‐Agramonte, M. D. L. Á., Gonçalves, C., Noris-García, E., Rivero, N. P., Brigida, A. L., Schultz, S. T., Siniscalco, D., & García, R. J. G. (2021) · World Journal of Psychiatry · doi:10.5498/wjp.v11.i7.347 · Cited by 38
Acute Transverse Myelitis Secondary to Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): A Case Report
Durrani, M., Kucharski, K., Smith, Z., & Fien, S. (2020) · Clinical Practice and Cases in Emergency Medicine · doi:10.5811/cpcem.2020.6.48462 · Cited by 37
Chronic neurological diseases and COVID-19: Associations and considerations
Meshkat, S., Salimi, A., Joshaghanian, A., Sedighi, S., Sedighi, S., & Aghamollaii, V. (2020) · Translational Neuroscience · doi:10.1515/tnsci-2020-0141 · Cited by 37
Drugs that offer the potential to reduce hospitalization and mortality from SARS-CoV-2 infection: The possible role of the sigma-1 receptor and autophagy
Brimson, J. M., Prasanth, M. I., Malar, D. S., Brimson, S., Thitilertdecha, P., & Tencomnao, T. (2021) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2021.1952987 · Cited by 36
Cerebrovascular and Neurological Dysfunction under the Threat of COVID-19: Is There a Comorbid Role for Smoking and Vaping?
Archie, S. R., & Cucullo, L. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21113916 · Cited by 37
SARS-CoV-2: Immune Response Elicited by Infection and Development of Vaccines and Treatments
Canedo-Marroquín, G., Saavedra, F., Andrade, C. A., Berríos-Rojas, R. V., Rodríguez‐Guilarte, L., Opazo, M. C., Riedel, C. A., & Kalergis, A. M. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.569760 · Cited by 40
De Novo Movement Disorders and COVID ‐19: Exploring the Interface
Ghosh, R., Biswas, U., Roy, D., Pandit, A., Lahiri, D., Ray, B. K., & Benito‐León, J. (2021) · Movement Disorders Clinical Practice · doi:10.1002/mdc3.13224 · Cited by 37
Investigating the potential mechanisms of depression induced-by COVID-19 infection in patients
Mohammadkhanizadeh, A., & Nikbakht, F. (2021) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2021.07.023 · Cited by 37
Biomedical Perspectives of Acute and Chronic Neurological and Neuropsychiatric Sequelae of COVID-19
Stefano, G. B., Büttiker, P., Weissenberger, S., Ptáček, R., Wang, F., Esch, T., Bilfinger, T. V., Raboch, J., & Kream, R. M. (2021) · Current Neuropharmacology · doi:10.2174/1570159x20666211223130228 · Cited by 38
Long COVID: plasma levels of neurofilament light chain in mild COVID-19 patients with neurocognitive symptoms
Gutman, E. G., Salvio, A. L., Fernandes, R. A., Duarte, L. A., Raposo-Vedovi, J. V., Alcaraz, H. F., Teixeira, M., Passos, G. F., Medeiros, K. Q. M. D., Hämmerle, M. B., et al. (2024) · Molecular Psychiatry · doi:10.1038/s41380-024-02554-0 · Cited by 39
Central Nervous System Manifestations of COVID-19: A Critical Review and Proposed Research Agenda
Hewitt, K. C., Marra, D. E., Block, C. K., Cysique, L. A., Drane, D. L., Haddad, M. M., Łojek, E., McDonald, C. R., Reyes, A., Eversole, K., et al. (2021) · Journal of the International Neuropsychological Society · doi:10.1017/s1355617721000345 · Cited by 36
The Impact of SARS-CoV-2 Infection on Youth Mental Health: A Narrative Review
Brasso, C., Bellino, S., Blua, C., Bozzatello, P., & Rocca, P. (2022) · Biomedicines · doi:10.3390/biomedicines10040772 · Cited by 39
Long-Term Effects of SARS-CoV-2 in the Brain: Clinical Consequences and Molecular Mechanisms
Granholm, A. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12093190 · Cited by 37
Neurological Complications of SARS-CoV, MERS-CoV, and COVID-19
Alshebri, M. S., Alshouimi, R. A., Alhumidi, H. A., & Alshaya, A. I. (2020) · SN Comprehensive Clinical Medicine · doi:10.1007/s42399-020-00589-2 · Cited by 36
Coronavirus disease 2019 and neurodegenerative disease: what will the future bring?
McAlpine, L. S., Fesharaki‐Zadeh, A., & Spudich, S. (2020) · Current Opinion in Psychiatry · doi:10.1097/yco.0000000000000688 · Cited by 36
SARS-CoV-2 Infection and Guillain-Barré Syndrome: A Review on Potential Pathogenic Mechanisms
Shoraka, S., Ferreira, M. L. B., Mohebbi, S. R., & Ghaemi, A. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.674922 · Cited by 34
Mind long COVID: Psychiatric sequelae of SARS-CoV-2 infection
Llach, C.-D., & Vieta, E. (2021) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2021.04.019 · Cited by 33
A comprehensive review of imaging findings in COVID-19 - status in early 2021
Afshar‐Oromieh, A., Prosch, H., Schaefer‐Prokop, C. M., Bohn, K. P., Alberts, I., Mingels, C., Thurnher, M. M., Cumming, P. D., Shi, K., Peters, A. A., et al. (2021) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-021-05375-3 · Cited by 35
Neurologic complications of coronavirus and other respiratory viral infections
Cavallieri, F., Sellner, J., Zedde, M., & Moro, E. (2022) · Handbook of clinical neurology · doi:10.1016/b978-0-323-91532-8.00004-5 · Cited by 32
Is anosmia the price to pay in an immune-induced scorched-earth policy against COVID-19?
Bon, S. D. L., & Horoi, M. (2020) · Medical Hypotheses · doi:10.1016/j.mehy.2020.109881 · Cited by 34
Neurological Consequences of 2019-nCoV Infection: A Comprehensive Literature Review
Azim, D., Nasim, S., Kumar, S., Hussain, A., & Patel, S. (2020) · Cureus · doi:10.7759/cureus.8790 · Cited by 33
Complications and Pathophysiology of COVID-19 in the Nervous System
Yu, H., Sun, T., & Feng, J. (2020) · Frontiers in Neurology · doi:10.3389/fneur.2020.573421 · Cited by 33
Psychopathology in Elderly COVID-19 Survivors and Controls
Mowla, A., Ghaedsharaf, M., & Pani, A. (2021) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/08919887211002664 · Cited by 33
Biological and Psychological Factors Determining Neuropsychiatric Outcomes in COVID-19
Tizenberg, B., Brenner, L. A., Lowry, C. A., Okusaga, O. O., Benavides, D. R., Hoisington, A. J., Benros, M. E., Stiller, J. W., Kessler, R. C., & Postolache, T. T. (2021) · Current Psychiatry Reports · doi:10.1007/s11920-021-01275-3 · Cited by 33
The Impact of SARS-CoV-2 Infection on the Development of Neurodegeneration in Multiple Sclerosis
Dziedzic, A., Saluk, J., Miller, E. D., Niemcewicz, M., & Bijak, M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22041804 · Cited by 33
Microbiota-Gut-Brain Communication in the SARS-CoV-2 Infection
Manosso, L. M., Arent, C. O., Borba, L. A., Ceretta, L. B., Quevedo, J., & Réus, G. Z. (2021) · Cells · doi:10.3390/cells10081993 · Cited by 36
Clinical Heterogeneity in ME/CFS. A Way to Understand Long-COVID19 Fatigue
Murga, Í., Aranburu, L., Gargiulo, P. Á., Gómez‐Esteban, J. C., & Lafuente, J. V. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.735784 · Cited by 32
Can SARS-CoV-2 Infection Lead to Neurodegeneration and Parkinson’s Disease?
Krey, L., Huber, M. K., Höglinger, G. U., & Wegner, F. (2021) · Brain Sciences · doi:10.3390/brainsci11121654 · Cited by 31
Command Suicidal Hallucination as Initial Presentation of Coronavirus Disease 2019 (COVID-19): A Case Report
Mirza, J., Ganguly, A., Ostrovskaya, A., Tusher, A., & Viswanathan, R. (2020) · Psychosomatics · doi:10.1016/j.psym.2020.05.022 · Cited by 31
Longitudinally extensive transverse myelitis following acute COVID-19 infection
Fumery, T., Baudar, C., Ossemann, M., & London, F. (2020) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2020.102723 · Cited by 31
Neurologic manifestations in children with COVID-19 from a tertiary center in Turkey and literature review
Gürlevik, S. L., Günbey, C., Özsürekçi, Y., Oygar, P. D., Kesici, S., Göçmen, R., Aydın, O., Temuçin, Ç. M., Tufan, E., Terzi, K., et al. (2022) · European Journal of Paediatric Neurology · doi:10.1016/j.ejpn.2022.02.003 · Cited by 31
Neurological manifestations of COVID-19: A systematic reviewPreprint
Chen, X., Laurent, S. A., Onur, O. A., Kleineberg, N. N., Fink, G. R., Schweitzer, F., & Warnke, C. (2020) · doi:10.21203/rs.3.rs-37601/v1 · Cited by 31
Respiratory Distress in SARS-CoV-2 without Lung Damage: Phrenic Paralysis Should Be Considered in COVID-19 Infection
Maurier, F., Godbert, B., & Perrin, J. (2020) · European Journal of Case Reports in Internal Medicine · doi:10.12890/2020_001728 · Cited by 30
Pain and Other Neurological Symptoms Are Present at 3 Months After Hospitalization in COVID-19 Patients
Savarraj, J. P. J., Burkett, A., Hinds, S. N., Paz, A. S., Assing, A., Juneja, S., Colpo, G. D., Torres, L. F., Cho, S., Gusdon, A. M., et al. (2021) · Frontiers in Pain Research · doi:10.3389/fpain.2021.737961 · Cited by 30
Astrocytes and the Psychiatric Sequelae of COVID-19: What We Learned from the Pandemic
Steardo, L., Steardo, L., & Scuderi, C. (2022) · Neurochemical Research · doi:10.1007/s11064-022-03709-7 · Cited by 34
Quinones as Promising Compounds against Respiratory Viruses: A Review
Chan‐Zapata, I., Borges-Argáez, R., & Ayora‐Talavera, G. (2023) · Molecules · doi:10.3390/molecules28041981 · Cited by 30
Neurological complications in a predominantly African American sample of COVID-19 predict worse outcomes during hospitalization
Chachkhiani, D., Soliman, M. Y., Barua, D., Isakadze, M., Villemarette-Pittman, N. R., Devier, D. J., & Lovera, J. F. (2020) · Clinical Neurology and Neurosurgery · doi:10.1016/j.clineuro.2020.106173 · Cited by 29
Perspectives for the use of therapeutic Botulinum toxin as a multifaceted candidate drug to attenuate COVID-19
Kandasamy, M. (2020) · Medicine in Drug Discovery · doi:10.1016/j.medidd.2020.100042 · Cited by 28
SARS-CoV-2 Infection: A Role for S1P/S1P Receptor Signaling in the Nervous System?
Meacci, E., Garcia‐Gil, M., & Pierucci, F. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21186773 · Cited by 29

Authors: Desforges, M., Le Coupanec, A., Dubeau, P., Bourgouin, A., Lajoie, L., Dubé, M., & Talbot, P. J.
Affiliations: Institut National de la Recherche Scientifique (CA)
Laboratory of Neuroimmunovirology, Institut national de la recherche scientifique (INRS)-Institut Armand-Frappier, Université du Québec, Laval, QC H7V 1B7, Canada
Université de Sherbrooke (CA)
Corresponding author: Desforges, Marc
Talbot, Pierre J.
ORCID: Desforges, Marc
Dubeau, Philippe
Talbot, Pierre J.
Venue: Viruses
Publisher: MDPI AG
Published: 2019-12-20
Volume: 12
Issue: 1
Pages: 14
ISSN: 1999-4915 (ISSN-L)
DOI: 10.3390/v12010014
PMC: PMC7020001
OpenAlex: W2995936855
Cited by: 1,048
References: 341
Citations by year: 2026: 16 · 2025: 32 · 2024: 59 · 2023: 101 · 2022: 200 · 2021: 323 · 2020: 314 · 2019: 3
FWCI: 29.51
Type: journal article
Language: en
Open access: gold
dx.doi.org
Licence: cc-by
creativecommons.org/licenses/by/4.0/ (vor)
Locations: Viruses (publishedVersion, cc-by)
Europe PMC (PubMed Central) (publishedVersion, cc-by)
PubMed Central (publishedVersion, cc-by)
PubMed (publishedVersion)
EspaceINRS (National Institute for Scientific Research (Canada)) (submittedVersion)
HAL (submittedVersion)
Informationszentrum Lebenswissenschaften (ZB MED) (submittedVersion, cc-by)
Funders: Canadian Institutes of Health Research (MT-9203)
Topics: Health Sciences › Medicine › Infectious Diseases › Infectious Encephalopathies and Encephalitis
Health Sciences › Medicine › Clinical Neurology › Long-Term Effects of COVID-19
Health Sciences › Medicine › Epidemiology › Respiratory viral infections research
Keywords: human coronaviruses, respiratory viruses, central nervous system infection, encephalitis, neuropathology, opportunistic pathogens, emerging respiratory viruses, influenza A virus, SARS-CoV, autoimmunity, neurological disorders
MeSH terms: Animals, Central Nervous System, Humans, Nervous System Diseases, Respiratory Tract Infections, Virus Replication, Coronavirus, Coronavirus Infections, Encephalitis, Viral, Central Nervous System Viral Diseases

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Human Coronaviruses and Other Respiratory Viruses: Underestimated Opportunistic Pathogens of the Central Nervous System?

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks